DNA methylation based biomarkers: Practical considerations and applications

Biochimie

Volumn 94, Issue 11, 2012, Pages 2314-2337

  How Kit, Alexandre ^a   Nielsen, Helene Myrtue ^a,b   Tost, Jörg ^a,c  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b AARHUS UNIVERSITY   (Denmark)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

Biomarker development; Cancer; DNA methylation; Early detection; Prenatal diagnosis

Indexed keywords

ANTHRACYCLINE; BIOLOGICAL MARKER; BISULFITE; CA 125 ANTIGEN; CCND2 PROTEIN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DACARBAZINE; DEATH ASSOCIATED PROTEIN KINASE; DNA; DOXORUBICIN; ERLOTINIB; GEFITINIB; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1; IFFO1 PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2; RETINOIC ACID RECEPTOR BETA; SUPPRESSOR OF CYTOKINE SIGNALING 1; TAMOXIFEN; TEMOZOLOMIDE; THBS1 PROTEIN; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

BLADDER CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PYROSEQUENCING; REVIEW; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA IN SITU;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC MARKERS; HUMANS; NEOPLASMS;

EID: 84867400649     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.07.014     Document Type: Review

References (323)

1. M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, and G.A. Calin MicroRNAs in body fluids-the mix of hormones and biomarkers Nature Reviews Clinical Oncology 8 2011 467 477
2. M. Fabbri miRNAs as molecular biomarkers of cancer Expert Review of Molecular Diagnostics 10 2010 435 444
3. A. Bird DNA methylation patterns and epigenetic memory Genes & Development 16 2002 6 21
4. S. Kriaucionis, and N. Heintz The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain Science 324 2009 929 930
5. M. Tahiliani, K.P. Koh, Y. Shen, W.A. Pastor, H. Bandukwala, Y. Brudno, S. Agarwal, L.M. Iyer, D.R. Liu, L. Aravind, and A. Rao Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 2009 930 935
6. A. Ruzov, Y. Tsenkina, A. Serio, T. Dudnakova, J. Fletcher, Y. Bai, T. Chebotareva, S. Pells, Z. Hannoun, G. Sullivan, S. Chandran, D.C. Hay, M. Bradley, I. Wilmut, and P. De Sousa Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development Cell Research 21 2011 1332 1342
7. D. Globisch, M. Munzel, M. Muller, S. Michalakis, M. Wagner, S. Koch, T. Bruckl, M. Biel, and T. Carell Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates PloS One 5 2010 e15367
8. A. Maiti, and A.C. Drohat Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites The Journal of Biological Chemistry 286 2011 35334 35338
9. Y.F. He, B.Z. Li, Z. Li, P. Liu, Y. Wang, Q. Tang, J. Ding, Y. Jia, Z. Chen, L. Li, Y. Sun, X. Li, Q. Dai, C.X. Song, K. Zhang, C. He, and G.L. Xu Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA Science 333 2011 1303 1307
10. R.J. Klose, and A.P. Bird Genomic DNA methylation: the mark and its mediators Trends in Biochemical Sciences 31 2006 89 97
11. O. Bogdanovic, and G.J. Veenstra DNA methylation and methyl-CpG binding proteins: developmental requirements and function Chromosoma 118 2009 549 565
12. M. Escamilla-Del-Arenal, S.T. da Rocha, and E. Heard Evolutionary diversity and developmental regulation of X-chromosome inactivation Human Genetics 130 2011 307 327
13. L.K. Abramowitz, and M.S. Bartolomei Genomic imprinting: recognition and marking of imprinted loci Current Opinion in Genetics & Development 2012 72 78
14. M. Hatziapostolou, and D. Iliopoulos Epigenetic aberrations during oncogenesis Cellular and Molecular Life Sciences: CMLS 68 2011 1681 1702
15. C.B. Yoo, and P.A. Jones Epigenetic therapy of cancer: past, present and future Nature Reviews Drug Discovery 5 2006 37 50
16. S.B. Baylin, and P.A. Jones A decade of exploring the cancer epigenome - biological and translational implications Nature Reviews Cancer 11 2011 726 734
17. M. Rodriguez-Paredes, and M. Esteller Cancer epigenetics reaches mainstream oncology Nature Medicine 17 2011 330 339
18. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
19. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
20. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
21. A. Balmain, J. Gray, and B. Ponder The genetics and genomics of cancer Nature Genetics 33 Suppl 2003 238 244
22. J.F. Costello, M.C. Fruhwald, D.J. Smiraglia, L.J. Rush, G.P. Robertson, X. Gao, F.A. Wright, J.D. Feramisco, P. Peltomaki, J.C. Lang, D.E. Schuller, L. Yu, C.D. Bloomfield, M.A. Caligiuri, A. Yates, R. Nishikawa, H. Su Huang, N.J. Petrelli, X. Zhang, M.S. O'Dorisio, W.A. Held, W.K. Cavenee, and C. Plass Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nature Genetics 24 2000 132 138
23. T. Nagasaka, J. Rhees, M. Kloor, J. Gebert, Y. Naomoto, C.R. Boland, and A. Goel Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers Cancer Research 70 2010 3098 3108
24. Y. Li, J. Zhu, G. Tian, N. Li, Q. Li, M. Ye, H. Zheng, J. Yu, H. Wu, J. Sun, H. Zhang, Q. Chen, R. Luo, M. Chen, Y. He, X. Jin, Q. Zhang, C. Yu, G. Zhou, Y. Huang, H. Cao, X. Zhou, S. Guo, X. Hu, X. Li, K. Kristiansen, L. Bolund, J. Xu, W. Wang, H. Yang, J. Wang, R. Li, S. Beck, and X. Zhang The DNA methylome of human peripheral blood mononuclear cells PLoS Biology 8 2010 e1000533
25. T. Mikeska, I.L. Candiloro, A. Dobrovic, The implications of heterogeneous DNA methylation for the accurate quantification of methylation, Epigenomics 2 561-573.
26. J.G. Herman, C.I. Civin, J.P. Issa, M.I. Collector, S.J. Sharkis, and S.B. Baylin Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies Cancer Research 57 1997 837 841
27. G. Garcia-Manero, H.M. Kantarjian, B. Sanchez-Gonzalez, H. Yang, G. Rosner, S. Verstovsek, M. Rytting, W.G. Wierda, F. Ravandi, C. Koller, L. Xiao, S. Faderl, Z. Estrov, J. Cortes, S. O'Brien, E. Estey, C. Bueso-Ramos, J. Fiorentino, E. Jabbour, and J.P. Issa Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia Blood 108 2006 3271 3279
28. B.H. Sohn, I.Y. Park, J.J. Lee, S.J. Yang, Y.J. Jang, K.C. Park, D.J. Kim, D.C. Lee, H.A. Sohn, T.W. Kim, H.S. Yoo, J.Y. Choi, Y.S. Bae, and Y.I. Yeom Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter Gastroenterology 138 2010 1898 1908
29. C. Nguyen, G. Liang, T.T. Nguyen, D. Tsao-Wei, S. Groshen, M. Lubbert, J.H. Zhou, W.F. Benedict, and P.A. Jones Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells Journal of the National Cancer Institute 93 2001 1465 1472
30. T. Ushijima, N. Watanabe, E. Okochi, A. Kaneda, T. Sugimura, and K. Miyamoto Fidelity of the methylation pattern and its variation in the genome Genome Research 13 2003 868 874
31. J.P. Issa CpG island methylator phenotype in cancer Nature Reviews Cancer 4 2004 988 993
32. R.A. Irizarry, C. Ladd-Acosta, B. Wen, Z. Wu, C. Montano, P. Onyango, H. Cui, K. Gabo, M. Rongione, M. Webster, H. Ji, J.B. Potash, S. Sabunciyan, and A.P. Feinberg The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores Nature Genetics 41 2009 178 186
33. K.D. Hansen, W. Timp, H.C. Bravo, S. Sabunciyan, B. Langmead, O.G. McDonald, B. Wen, H. Wu, Y. Liu, D. Diep, E. Briem, K. Zhang, R.A. Irizarry, and A.P. Feinberg Increased methylation variation in epigenetic domains across cancer types Nature Genetics 43 2011 768 775
34. A.P. Bird, and E.M. Southern Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis Journal of Molecular Biology 118 1978 27 47
35. M.J. Fazzari, and J.M. Greally Epigenomics: beyond CpG islands Nature Reviews Genetics 5 2004 446 455
36. M. Weber, J.J. Davies, D. Wittig, E.J. Oakeley, M. Haase, W.L. Lam, and D. Schubeler Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells Nature Genetics 37 2005 853 862
37. T.A. Down, V.K. Rakyan, D.J. Turner, P. Flicek, H. Li, E. Kulesha, S. Graf, N. Johnson, J. Herrero, E.M. Tomazou, N.P. Thorne, L. Backdahl, M. Herberth, K.L. Howe, D.K. Jackson, M.M. Miretti, J.C. Marioni, E. Birney, T.J. Hubbard, R. Durbin, S. Tavare, and S. Beck A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis Nature Biotechnology 26 2008 779 785
38. A. Feber, G. Wilson, L. Zhang, N. Presneau, B. Idowu, T.A. Down, V.K. Rakyan, E. Stupka, V. Schiza, A. Teschendorff, G.P. Schroth, A. Flanagan, and S. Beck Comparative methylome analysis of benign and malignant peripheral nerve sheath tumours Genome Research 21 2011 515 524
39. T. Rauch, and G.P. Pfeifer Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer Laboratory Investigation 85 2005 1172 1180
40. A.B. Brinkman, F. Simmer, K. Ma, A. Kaan, J. Zhu, and H.G. Stunnenberg Whole-genome DNA methylation profiling using methylCap-seq Methods 52 2010 232 236
41. M. Frommer, L.E. McDonald, D.S. Millar, C.M. Collis, F. Watt, G.W. Grigg, P.L. Molloy, and C.L. Paul A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proceedings of the National Academy of Sciences of the United States of America 89 1992 1827 1831
42. B.A. Flusberg, D.R. Webster, J.H. Lee, K.J. Travers, E.C. Olivares, T.A. Clark, J. Korlach, and S.W. Turner Direct detection of DNA methylation during single-molecule, real-time sequencing Nature Methods 7 2010 461 465
43. C.X. Song, T.A. Clark, X.Y. Lu, A. Kislyuk, Q. Dai, S.W. Turner, C. He, and J. Korlach Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine Nature Methods 9 2012 75 77
44. J. Clarke, H.C. Wu, L. Jayasinghe, A. Patel, S. Reid, and H. Bayley Continuous base identification for single-molecule nanopore DNA sequencing Nature Nanotechnology 4 2009 265 270
45. J. Tost Methods for the genome-wide and gene-specific analysis of DNA methylation levels and patterns J. Tost, Epigenetics 2008 Horizon Scientific Press Norwich 63 104
46. P.W. Laird Principles and challenges of genome-wide DNA methylation analysis Nature Reviews Genetics 11 2010 191 203
47. C.S. Ku, N. Naidoo, M. Wu, and R. Soong Studying the epigenome using next generation sequencing Journal of Medical Genetics 48 2011 721 730
48. C. Bock, E.M. Tomazou, A.B. Brinkman, F. Muller, F. Simmer, H. Gu, N. Jager, A. Gnirke, H.G. Stunnenberg, and A. Meissner Quantitative comparison of genome-wide DNA methylation mapping technologies Nature Biotechnology 28 2010 1106 1114
49. A. Meissner, T.S. Mikkelsen, H. Gu, M. Wernig, J. Hanna, A. Sivachenko, X. Zhang, B.E. Bernstein, C. Nusbaum, D.B. Jaffe, A. Gnirke, R. Jaenisch, and E.S. Lander Genome-scale DNA methylation maps of pluripotent and differentiated cells Nature 454 2008 766 770
50. R.A. Harris, T. Wang, C. Coarfa, R.P. Nagarajan, C. Hong, S.L. Downey, B.E. Johnson, S.D. Fouse, A. Delaney, Y. Zhao, A. Olshen, T. Ballinger, X. Zhou, K.J. Forsberg, J. Gu, L. Echipare, H. O'Geen, R. Lister, M. Pelizzola, Y. Xi, C.B. Epstein, B.E. Bernstein, R.D. Hawkins, B. Ren, W.Y. Chung, H. Gu, C. Bock, A. Gnirke, M.Q. Zhang, D. Haussler, J.R. Ecker, W. Li, P.J. Farnham, R.A. Waterland, A. Meissner, M.A. Marra, M. Hirst, A. Milosavljevic, and J.F. Costello Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications Nature Biotechnology 28 2010 1097 1105
51. M.D. Robinson, A.L. Statham, T.P. Speed, and S.J. Clark Protocol matters: which methylome are you actually studying? Epigenomics 2 2010 587 598
52. M. Bibikova, J. Le, B. Barnes, S. Saedinia-Melnyk, L. Zhou, R. Shen, and K.L. Gunderson Genome-wide DNA methylation profiling using Infinium((R)) assay Epigenomics 1 2009 177 200
53. J. Sandoval, H. Heyn, S. Moran, J. Serra-Musach, M.A. Pujana, M. Bibikova, and M. Esteller Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome Epigenetics 6 2011 692 702
54. M. Bibikova, B. Barnes, C. Tsan, V. Ho, B. Klotzle, J.M. Le, D. Delano, L. Zhang, G.P. Schroth, K.L. Gunderson, J.B. Fan, and R. Shen High density DNA methylation array with single CpG site resolution Genomics 98 2011 288 295
55. S. Dedeurwaerder, M. Defrance, E. Calonne, H. Denis, C. Sotiriou, and F. Fuks Evaluation of the Infinium methylation 450K technology Epigenomics 3 2011 771 784
56. N. Touleimat, and J. Tost Complete pipeline for Infinium((R)) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation Epigenomics 4 2012 325 341
57. D. Wang, L. Yan, Q. Hu, L.E. Sucheston, M.J. Higgins, C.B. Ambrosone, C.S. Johnson, D.J. Smiraglia, and S. Liu IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data Bioinformatics 28 2012 729 730
58. M. Campan, M. Moffitt, S. Houshdaran, H. Shen, M. Widschwendter, G. Daxenbichler, T. Long, C. Marth, I.A. Laird-Offringa, M.F. Press, L. Dubeau, K.D. Siegmund, A.H. Wu, S. Groshen, U. Chandavarkar, L.D. Roman, A. Berchuck, C.L. Pearce, and P.W. Laird Genome-scale screen for DNA methylation-based detection markers for ovarian cancer PLoS One 6 2011 e28141
59. R.A. Philibert, J.M. Plume, F.X. Gibbons, G.H. Brody, and S.R. Beach The impact of recent alcohol use on genome wide DNA methylation signatures Frontiers in Genetics 3 2012 54
60. K. Walter, T. Holcomb, T. Januario, P. Du, M. Evangelista, N. Kartha, L. Iniguez, R. Soriano, L. Huw, H. Stern, Z. Modrusan, S. Seshagiri, G.M. Hampton, L.C. Amler, R. Bourgon, R.L. Yauch, and D.S. Shames DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer Clinical Cancer Research 18 2012 2360 2373
61. P.W. Laird Early detection: the power and the promise of DNA methylation markers Nature Reviews Cancer 3 2003 253 266
62. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, C. Blake, D. Shibata, P.V. Danenberg, and P.W. Laird MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Research 28 2000 E32
63. S.E. Cottrell, J. Distler, N.S. Goodman, S.H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin A real-time PCR assay for DNA-methylation using methylation-specific blockers Nucleic Acids Research 32 2004 e10
64. T.K. Wojdacz, and A. Dobrovic Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation Nucleic Acids Research 35 2007 e41
65. L.S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic Sensitive melting analysis after real time- methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection Nucleic Acids Research 36 2008 e42
66. R.L. Yauch, T. Januario, D.A. Eberhard, G. Cavet, W. Zhu, L. Fu, T.Q. Pham, R. Soriano, J. Stinson, S. Seshagiri, Z. Modrusan, C.Y. Lin, V. O'Neill, and L.C. Amler Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 11 2005 8686 8698
67. P. Schuffler, T. Mikeska, A. Waha, T. Lengauer, and C. Bock MethMarker: user-friendly design and optimization of gene-specific DNA methylation assays Genome Biology 10 2009 R105
68. A.P. Feinberg, R. Ohlsson, and S. Henikoff The epigenetic progenitor origin of human cancer Nature Reviews Genetics 7 2006 21 33
69. S.E. Goelz, B. Vogelstein, S.R. Hamilton, and A.P. Feinberg Hypomethylation of DNA from benign and malignant human colon neoplasms Science 228 1985 187 190
70. T.H. Um, H. Kim, B.K. Oh, M.S. Kim, K.S. Kim, G. Jung, and Y.N. Park Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis Journal of Hepatology 54 2011 939 947
71. P. Kaur, S. Mani, M.P. Cros, J.Y. Scoazec, I. Chemin, P. Hainaut, and Z. Herceg Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma Tumour Biology 33 2012 325 336
72. N. Hanoun, Y. Delpu, A.A. Suriawinata, B. Bournet, C. Bureau, J. Selves, G.J. Tsongalis, M. Dufresne, L. Buscail, P. Cordelier, and J. Torrisani The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis Clinical Chemistry 56 2010 1107 1118
73. P. Garcia, C. Manterola, J.C. Araya, M. Villaseca, P. Guzman, A. Sanhueza, M. Thomas, H. Alvarez, and J.C. Roa Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions Molecular Carcinogenesis 48 2009 79 89
74. J.J. Eijsink, N. Yang, A. Lendvai, H.G. Klip, H.H. Volders, H.J. Buikema, B.M. van Hemel, M. Voll, H.J. Coelingh Bennink, E. Schuuring, G.B. Wisman, and A.G. van der Zee Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study Gynecologic Oncology 120 2011 280 283
75. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nature Reviews Cancer 6 2006 107 116
76. J.P. Issa, N. Ahuja, M. Toyota, M.P. Bronner, and T.A. Brentnall Accelerated age-related CpG island methylation in ulcerative colitis Cancer Research 61 2001 3573 3577
77. W.A. Palmisano, K.K. Divine, G. Saccomanno, F.D. Gilliland, S.B. Baylin, J.G. Herman, and S.A. Belinsky Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Research 60 2000 5954 5958
78. A. Scesnaite, S. Jarmalaite, P. Mutanen, S. Anttila, F. Nyberg, S. Benhamou, P. Boffetta, and K. Husgafvel-Pursiainen Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure Mutagenesis 27 2012 423 429
79. J.J. Eijsink, A. Lendvai, V. Deregowski, H.G. Klip, G. Verpooten, L. Dehaspe, G.H. de Bock, H. Hollema, W. van Criekinge, E. Schuuring, A.G. van der Zee, and G.B. Wisman A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients International Journal of Cancer 130 2012 1861 1869
80. S. Jahr, H. Hentze, S. Englisch, D. Hardt, F.O. Fackelmayer, R.D. Hesch, and R. Knippers DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Research 61 2001 1659 1665
81. J.M. Silva, G. Dominguez, J.M. Garcia, R. Gonzalez, M.J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations Cancer Research 59 1999 3251 3256
82. H. Schwarzenbach, D.S. Hoon, and K. Pantel Cell-free nucleic acids as biomarkers in cancer patients Nature Reviews Cancer 11 2011 426 437
83. M. Fleischhacker, and B. Schmidt Circulating nucleic acids (CNAs) and cancer-a survey Biochimica et Biophysica Acta 1775 2007 181 232
84. M. Esteller, P.G. Corn, S.B. Baylin, and J.G. Herman A gene hypermethylation profile of human cancer Cancer Research 61 2001 3225 3229
85. J.M. Teodoridis, C. Hardie, and R. Brown CpG island methylator phenotype (CIMP) in cancer: causes and implications Cancer Letters 268 2008 177 186
86. H. Noushmehr, D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, and K. Aldape Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
87. Y.K. Bae, A. Brown, E. Garrett, D. Bornman, M.J. Fackler, S. Sukumar, J.G. Herman, and E. Gabrielson Hypermethylation in histologically distinct classes of breast cancer Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 10 2004 5998 6005
88. M. Toyota, C. Ho, N. Ahuja, K.W. Jair, Q. Li, M. Ohe-Toyota, S.B. Baylin, and J.P. Issa Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification Cancer Research 59 1999 2307 2312
89. L. Shen, P.J. Catalano, A.B. Benson 3rd, P. O'Dwyer, S.R. Hamilton, and J.P. Issa Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 13 2007 6093 6098
90. C. Maesawa, G. Tamura, S. Nishizuka, S. Ogasawara, K. Ishida, M. Terashima, K. Sakata, N. Sato, K. Saito, and R. Satodate Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma Cancer Research 56 1996 3875 3878
91. D.L. Mandelker, K. Yamashita, Y. Tokumaru, K. Mimori, D.L. Howard, Y. Tanaka, A.L. Carvalho, W.-W. Jiang, H.L. Park, M.S. Kim, M. Osada, M. Mori, and D. Sidransky PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma Cancer Research 65 2005 4963 4968
92. K. Kawakami, J. Brabender, R.V. Lord, S. Groshen, B.D. Greenwald, M.J. Krasna, J. Yin, A.S. Fleisher, J.M. Abraham, D.G. Beer, D. Sidransky, H.T. Huss, T.R. Demeester, C. Eads, P.W. Laird, D.H. Ilson, D.P. Kelsen, D. Harpole, M.B. Moore, K.D. Danenberg, P.V. Danenberg, and S.J. Meltzer Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma Journal of the National Cancer Institute 92 2000 1805 1811
93. M. Sanchez-Cespedes, M. Esteller, L. Wu, H. Nawroz-Danish, G.H. Yoo, W.M. Koch, J. Jen, J.G. Herman, and D. Sidransky Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Research 60 2000 892 895
94. X. Tang, F.R. Khuri, J.J. Lee, B.L. Kemp, D. Liu, W.K. Hong, and L. Mao Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer Journal of the National Cancer Institute 92 2000 1511 1516
95. D.H. Kim, H.H. Nelson, J.K. Wiencke, S. Zheng, D.C. Christiani, J.C. Wain, E.J. Mark, and K.T. Kelsey p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer Cancer Research 61 2001 3419 3424
96. J. Brabender, H. Usadel, K.D. Danenberg, R. Metzger, P.M. Schneider, R.V. Lord, K. Wickramasinghe, C.E. Lum, J. Park, D. Salonga, J. Singer, D. Sidransky, A.H. Hölscher, S.J. Meltzer, and P.V. Danenberg Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival Oncogene 20 2001 3528 3532
97. H. Usadel, J. Brabender, K.D. Danenberg, C. Jerónimo, S. Harden, J. Engles, P.V. Danenberg, S. Yang, and D. Sidransky Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Research 62 2002 371 375
98. J. Brabender, H. Usadel, R. Metzger, P.M. Schneider, J. Park, D. Salonga, D.D. Tsao-Wei, S. Groshen, R.V. Lord, N. Takebe, S. Schneider, A.H. Hölscher, K.D. Danenberg, and P.V. Danenberg Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9 2003 223 227
99. H.-S. Hsu, C.-K. Wen, Y.-A. Tang, R.-K. Lin, W.-Y. Li, W.-H. Hsu, and Y.-C. Wang Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11 2005 5410 5416
100. I.H. Wong, Y.M. Lo, W. Yeo, W.Y. Lau, and P.J. Johnson Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6 2000 3516 3521
101. G. Domínguez, J. Carballido, J. Silva, J.M. Silva, J.M. García, J. Menéndez, M. Provencio, P. España, and F. Bonilla p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8 2002 980 985
102. F. Christoph, S. Weikert, C. Kempkensteffen, H. Krause, M. Schostak, K. Miller, and M. Schrader Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder International Journal of Cancer. Journal International Du Cancer 119 2006 1396 1402
103. H. Zou, B. Yu, R. Zhao, Z. Wang, H. Cang, D. Li, G. Feng, and J. Yi Detection of aberrant p16 methylation in the serum of colorectal cancer patients Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine] 36 2002 499 501
104. T. Lecomte, A. Berger, F. Zinzindohoué, S. Micard, B. Landi, H. Blons, P. Beaune, P.-H. Cugnenc, and P. Laurent-Puig Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis International Journal of Cancer. Journal International Du Cancer 100 2002 542 548
105. A. Widschwendter, L. Ivarsson, A. Blassnig, H.M. Müller, H. Fiegl, A. Wiedemair, E. Müller-Holzner, G. Goebel, C. Marth, and M. Widschwendter CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients International Journal of Cancer. Journal International Du Cancer 109 2004 163 166
106. Z.R. Qian, T. Sano, K. Yoshimoto, S.L. Asa, S. Yamada, N. Mizusawa, and E. Kudo Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc 20 2007 1269 1277
107. H.M. Müller, A. Widschwendter, H. Fiegl, L. Ivarsson, G. Goebel, E. Perkmann, C. Marth, and M. Widschwendter DNA methylation in serum of breast cancer patients: an independent prognostic marker Cancer Research 63 2003 7641 7645
108. X. Xu, M.D. Gammon, Y. Zhang, T.H. Bestor, S.H. Zeisel, J.G. Wetmur, S. Wallenstein, P.T. Bradshaw, G. Garbowski, S.L. Teitelbaum, A.I. Neugut, R.M. Santella, and J. Chen BRCA1 promoter methylation is associated with increased mortality among women with breast cancer Breast Cancer Research and Treatment 115 2009 397 404
109. R. Maruyama, S. Toyooka, K.O. Toyooka, A.K. Virmani, S. Zöchbauer-Müller, A.J. Farinas, J.D. Minna, J. McConnell, E.P. Frenkel, and A.F. Gazdar Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8 2002 514 519
110. M.V. Brock, C.M. Hooker, E. Ota-Machida, Y. Han, M. Guo, S. Ames, S. Glockner, S. Piantadosi, E. Gabrielson, G. Pridham, K. Pelosky, S.A. Belinsky, S.C. Yang, S.B. Baylin, and J.G. Herman DNA methylation markers and early recurrence in stage I lung cancer The New England Journal of Medicine 358 2008 1118 1128
111. M.V. Brock, M. Gou, Y. Akiyama, A. Muller, T.-T. Wu, E. Montgomery, M. Deasel, P. Germonpré, L. Rubinson, R.F. Heitmiller, S.C. Yang, A.A. Forastiere, S.B. Baylin, and J.G. Herman Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9 2003 2912 2919
112. J.R. Fischer, U. Ohnmacht, N. Rieger, M. Zemaitis, C. Stoffregen, M. Kostrzewa, E. Buchholz, C. Manegold, and H. Lahm Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma Lung Cancer (Amsterdam, Netherlands) 54 2006 109 116
113. J.L. Brandsma, Y. Sun, P.M. Lizardi, D.P. Tuck, D. Zelterman, G.K. Haines 3rd, M. Martel, M. Harigopal, K. Schofield, and M. Neapolitano Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy Virology 389 2009 100 107
114. S. Vinokurova, and M. von Knebel Doeberitz Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation PLoS ONE 6 2011 e24451
115. S.H. Wei, C.-M. Chen, G. Strathdee, J. Harnsomburana, C.-R. Shyu, F. Rahmatpanah, H. Shi, S.-W. Ng, P.S. Yan, K.P. Nephew, R. Brown, and T.H.-M. Huang Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8 2002 2246 2252
116. S.H. Wei, C. Balch, H.H. Paik, Y.-S. Kim, R.L. Baldwin, S. Liyanarachchi, L. Li, Z. Wang, J.C. Wan, R.V. Davuluri, B.Y. Karlan, G. Gifford, R. Brown, S. Kim, T.H.M. Huang, and K.P. Nephew Prognostic DNA methylation biomarkers in ovarian cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12 2006 2788 2794
117. W. Dai, J.M. Teodoridis, C. Zeller, J. Graham, J. Hersey, J.M. Flanagan, E. Stronach, D.W. Millan, N. Siddiqui, J. Paul, and R. Brown Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17 2011 4052 4062
118. K. Gyobu, S. Yamashita, Y. Matsuda, H. Igaki, T. Niwa, D. Oka, R. Kushima, H. Osugi, S. Lee, S. Suehiro, and T. Ushijima Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas Annals of Surgical Oncology 18 2011 1185 1194
119. M.E. Figueroa, S. Lugthart, Y. Li, C. Erpelinck-Verschueren, X. Deng, P.J. Christos, E. Schifano, J. Booth, W. van Putten, L. Skrabanek, F. Campagne, M. Mazumdar, J.M. Greally, P.J.M. Valk, B. Löwenberg, R. Delwel, and A. Melnick DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer Cell 17 2010 13 27
120. S. Deneberg, M. Grövdal, M. Karimi, M. Jansson, H. Nahi, A. Corbacioglu, V. Gaidzik, K. Döhner, C. Paul, T.J. Ekström, E. Hellström-Lindberg, and S. Lehmann Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia, Leukemia Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K 24 2010 932 941
121. M.J. Fackler, C.B. Umbricht, D. Williams, P. Argani, L.-A. Cruz, V.F. Merino, W.W. Teo, Z. Zhang, P. Huang, K. Visvananthan, J. Marks, S. Ethier, J.W. Gray, A.C. Wolff, L.M. Cope, and S. Sukumar Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence Cancer Research 71 2011 6195 6207
122. A. Etcheverry, M. Aubry, M. de Tayrac, E. Vauleon, R. Boniface, F. Guenot, S. Saikali, A. Hamlat, L. Riffaud, P. Menei, V. Quillien, and J. Mosser DNA methylation in glioblastoma: impact on gene expression and clinical outcome BMC Genomics 11 2010 701
123. J.M. Yi, M. Dhir, L. Van Neste, S.R. Downing, J. Jeschke, S.C. Glöckner, M. de Freitas Calmon, C.M. Hooker, J.M. Funes, C. Boshoff, K.M. Smits, M. van Engeland, M.P. Weijenberg, C.A. Iacobuzio-Donahue, J.G. Herman, K.E. Schuebel, S.B. Baylin, and N. Ahuja Genomic and epigenomic integration identifies a prognostic signature in colon cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17 2011 1535 1545
124. M. Widschwendter, K.D. Siegmund, H.M. Müller, H. Fiegl, C. Marth, E. Müller-Holzner, P.A. Jones, and P.W. Laird Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen Cancer Research 64 2004 3807 3813
125. J.W.M. Martens, I. Nimmrich, T. Koenig, M.P. Look, N. Harbeck, F. Model, A. Kluth, J. Bolt-de Vries, A.M. Sieuwerts, H. Portengen, M.E. Meijer-Van Gelder, C. Piepenbrock, A. Olek, H. Höfler, M. Kiechle, J.G.M. Klijn, M. Schmitt, S. Maier, and J.A. Foekens Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer Cancer Research 65 2005 4101 4117
126. H.G. Chang, S.J. Kim, K.-W. Chung, D.-Y. Noh, Y. Kwon, E.S. Lee, and H.-S. Kang Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene Journal of Molecular Medicine (Berlin, Germany) 83 2005 132 139
127. S. Maier, I. Nimmrich, T. Koenig, S. Eppenberger-Castori, I. Bohlmann, A. Paradiso, F. Spyratos, C. Thomssen, V. Mueller, J. Nährig, F. Schittulli, R. Kates, R. Lesche, I. Schwope, A. Kluth, A. Marx, J.W.M. Martens, J.A. Foekens, M. Schmitt, and N. Harbeck DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients-technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) pathobiology group European Journal of Cancer (Oxford, England: 1990) 43 2007 1679 1686
128. N. Harbeck, I. Nimmrich, A. Hartmann, J.S. Ross, T. Cufer, R. Grützmann, G. Kristiansen, A. Paradiso, O. Hartmann, A. Margossian, J. Martens, I. Schwope, A. Lukas, V. Müller, K. Milde-Langosch, J. Nährig, J. Foekens, S. Maier, M. Schmitt, and R. Lesche Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26 2008 5036 5042
129. O. Hartmann, F. Spyratos, N. Harbeck, D. Dietrich, A. Fassbender, M. Schmitt, S. Eppenberger-Castori, V. Vuaroqueaux, F. Lerebours, K. Welzel, S. Maier, A. Plum, S. Niemann, J.A. Foekens, R. Lesche, and J.W.M. Martens DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15 2009 315 323
130. E. Dejeux, J.A. Ronneberg, H. Solvang, I. Bukholm, S. Geisler, T. Aas, I.G. Gut, A.L. Borresen-Dale, P.E. Lonning, V.N. Kristensen, and J. Tost DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response Molecular Cancer 9 2010 68
131. J. Veeck, S. Ropero, F. Setien, E. Gonzalez-Suarez, A. Osorio, J. Benitez, J.G. Herman, and M. Esteller BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors Journal of Clinical Oncology 28 2010 e563 564 author reply e565-566
132. M.S. Soengas, P. Capodieci, D. Polsky, J. Mora, M. Esteller, X. Opitz-Araya, R. McCombie, J.G. Herman, W.L. Gerald, Y.A. Lazebnik, C. Cordon-Cardo, and S.W. Lowe Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Nature 409 2001 207 211
133. M.S. Soengas, and S.W. Lowe Apoptosis and melanoma chemoresistance Oncogene 22 2003 3138 3151
134. P. Chaudhry, R. Srinivasan, and F.D. Patel Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC) Cancer Investigation 27 2009 877 884
135. M. Esteller, J. Garcia-Foncillas, E. Andion, S.N. Goodman, O.F. Hidalgo, V. Vanaclocha, S.B. Baylin, and J.G. Herman Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents The New England Journal of Medicine 343 2000 1350 1354
136. M.E. Hegi, A.-C. Diserens, S. Godard, P.-Y. Dietrich, L. Regli, S. Ostermann, P. Otten, G. Van Melle, N. de Tribolet, and R. Stupp Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10 2004 1871 1874
137. M.F. Paz, R. Yaya-Tur, I. Rojas-Marcos, G. Reynes, M. Pollan, L. Aguirre-Cruz, J.L. García-Lopez, J. Piquer, M.-J. Safont, C. Balaña, M. Sanchez-Cespedes, M. García-Villanueva, L. Arribas, and M. Esteller CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10 2004 4933 4938
138. T. Mori, S.J. O'Day, N. Umetani, S.R. Martinez, M. Kitago, K. Koyanagi, C. Kuo, T.-L. Takeshima, R. Milford, H.-J. Wang, V.D. Vu, S.L. Nguyen, and D.S.B. Hoon Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23 2005 9351 9358
139. J. Brabender, D. Arbab, X. Huan, D. Vallböhmer, P. Grimminger, F. Ling, S. Neiss, E. Bollschweiler, P.M. Schneider, A.H. Hölscher, and R. Metzger Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer Annals of Surgical Oncology 16 2009 1378 1383
140. T. Suzuki, K. Yoshida, Y. Wada, Y. Hamai, K. Sentani, N. Oue, and W. Yasui Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer Oncology Reports 18 2007 329 336
141. C.K. Augustine, J.S. Yoo, A. Potti, Y. Yoshimoto, P.A. Zipfel, H.S. Friedman, J.R. Nevins, F. Ali-Osman, and D.S. Tyler Genomic and molecular profiling predicts response to temozolomide in melanoma Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15 2009 502 510
142. A. Gomez, and M. Ingelman-Sundberg Pharmacoepigenetics: its role in interindividual differences in drug response Clinical Pharmacology & Therapeutics 85 2009 426 430
143. M. Kacevska, M. Ivanov, and M. Ingelman-Sundberg Perspectives on epigenetics and its relevance to adverse drug reactions Clinical Pharmacology & Therapeutics 89 2011 902 907
144. T. Hinoue, D.J. Weisenberger, C.P. Lange, H. Shen, H.M. Byun, D. Van Den Berg, S. Malik, F. Pan, H. Noushmehr, C.M. van Dijk, R.A. Tollenaar, and P.W. Laird Genome-scale analysis of aberrant DNA methylation in colorectal cancer Genome Research 22 2012 271 282
145. M.D. Robinson, C. Stirzaker, A.L. Statham, M.W. Coolen, J.Z. Song, S.S. Nair, D. Strbenac, T.P. Speed, and S.J. Clark Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation Genome Research 20 2010 1719 1729
146. E.A. Houseman, B.C. Christensen, M.R. Karagas, M.R. Wrensch, H.H. Nelson, J.L. Wiemels, S. Zheng, J.K. Wiencke, K.T. Kelsey, and C.J. Marsit Copy number variation has little impact on bead-array-based measures of DNA methylation Bioinformatics 25 2009 1999 2005
147. M. Lauss, M. Aine, G. Sjodahl, S. Veerla, O. Patschan, S. Gudjonsson, G. Chebil, K. Lovgren, M. Ferno, W. Mansson, F. Liedberg, M. Ringner, D. Lindgren, M. Hoglund, DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status, Epigenetics, in press.
148. M.D. Wilkerson, X. Yin, V. Walter, N. Zhao, C.R. Cabanski, M.C. Hayward, C.R. Miller, M.A. Socinski, A.M. Parsons, L.B. Thorne, B.E. Haithcock, N.K. Veeramachaneni, W.K. Funkhouser, S.H. Randell, P.S. Bernard, C.M. Perou, and D.N. Hayes Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation PLoS ONE 7 2012 e36530
149. Z. Sun, Y.W. Asmann, K.R. Kalari, B. Bot, J.E. Eckel-Passow, T.R. Baker, J.M. Carr, I. Khrebtukova, S. Luo, L. Zhang, G.P. Schroth, E.A. Perez, and E.A. Thompson Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing PLoS ONE 6 2011 e17490
150. J.T. Bell, A.A. Pai, J.K. Pickrell, D.J. Gaffney, R. Pique-Regi, J.F. Degner, Y. Gilad, and J.K. Pritchard DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines Genome Biology 12 2011 R10
151. E.R. Gamazon, J.A. Badner, L. Cheng, C. Zhang, D. Zhang, N.J. Cox, E.S. Gershon, J.R. Kelsoe, T.A. Greenwood, C.M. Nievergelt, C. Chen, R. McKinney, P.D. Shilling, N.J. Schork, E.N. Smith, C.S. Bloss, J.I. Nurnberger, H.J. Edenberg, T. Foroud, D.L. Koller, W.A. Scheftner, W. Coryell, J. Rice, W.B. Lawson, E.A. Nwulia, M. Hipolito, W. Byerley, F.J. McMahon, T.G. Schulze, W.H. Berrettini, J.B. Potash, P.P. Zandi, P.B. Mahon, M.G. McInnis, S. Zollner, P. Zhang, D.W. Craig, S. Szelinger, T.B. Barrett, C. Liu, Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants, Molecular Psychiatry, in press.
152. J.A. Ronneberg, J. Tost, H.K. Solvang, G.I. Alnaes, F.E. Johansen, E.M. Brendeford, Z. Yakhini, I.G. Gut, P.E. Lonning, A.L. Borresen-Dale, O.S. Gabrielsen, and V.N. Kristensen GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas Cancer Research 68 2008 5562 5571
153. C.G. Bell, S. Finer, C.M. Lindgren, G.A. Wilson, V.K. Rakyan, A.E. Teschendorff, P. Akan, E. Stupka, T.A. Down, I. Prokopenko, I.M. Morison, J. Mill, R. Pidsley, P. Deloukas, T.M. Frayling, A.T. Hattersley, M.I. McCarthy, S. Beck, and G.A. Hitman Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus PLoS ONE 5 2010 e14040
154. J.A. Ronneberg, T. Fleischer, H.K. Solvang, S.H. Nordgard, H. Edvardsen, I. Potapenko, D. Nebdal, C. Daviaud, I. Gut, I. Bukholm, B. Naume, A.L. Borresen-Dale, J. Tost, and V. Kristensen Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer Molecular Oncology 5 2011 61 76
155. S. Kamalakaran, V. Varadan, H.E. Giercksky Russnes, D. Levy, J. Kendall, A. Janevski, M. Riggs, N. Banerjee, M. Synnestvedt, E. Schlichting, R. Karesen, K. Shama Prasada, H. Rotti, R. Rao, L. Rao, M.H. Eric Tang, K. Satyamoorthy, R. Lucito, M. Wigler, N. Dimitrova, B. Naume, A.L. Borresen-Dale, and J.B. Hicks DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables Molecular Oncology 5 2011 77 92
156. H. Easwaran, and S.B. Baylin Biomarkers for EGFR-Antagonist response: in the genes and on the genes! Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 18 2012 2121 2123
157. Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
158. L. Van Neste, J.G. Herman, G. Otto, J.W. Bigley, J.I. Epstein, and W. Van Criekinge The Epigenetic promise for prostate cancer diagnosis The Prostate 72 2012 1248 1261
159. J. You, P. Cozzi, B. Walsh, M. Willcox, J. Kearsley, P. Russell, and Y. Li Innovative biomarkers for prostate cancer early diagnosis and progression Critical Reviews in Oncology/Hematology 73 2010 10 22
160. E. Laborde Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death Cell Death and Differentiation 17 2010 1373 1380
161. D.S. Millar, C.L. Paul, P.L. Molloy, and S.J. Clark A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5′-end of the GSTP1 CpG island The Journal of Biological Chemistry 275 2000 24893 24899
162. W.H. Lee, R.A. Morton, J.I. Epstein, J.D. Brooks, P.A. Campbell, G.S. Bova, W.S. Hsieh, W.B. Isaacs, and W.G. Nelson Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis Proceedings of the National Academy of Sciences of the United States of America 91 1994 11733 11737
163. X. Lin, M. Tascilar, W.H. Lee, W.J. Vles, B.H. Lee, R. Veeraswamy, K. Asgari, D. Freije, B. van Rees, W.R. Gage, G.S. Bova, W.B. Isaacs, J.D. Brooks, T.L. DeWeese, A.M. De Marzo, and W.G. Nelson GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells The American Journal of Pathology 159 2001 1815 1826
164. C. Jerónimo, H. Usadel, R. Henrique, C. Silva, J. Oliveira, C. Lopes, and D. Sidransky Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer Urology 60 2002 1131 1135
165. M. Ramos-Gomez, M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T.W. Kensler Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proceedings of the National Academy of Sciences of the United States of America 98 2001 3410 3415
166. W.H. Lee, W.B. Isaacs, G.S. Bova, and W.G. Nelson CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 6 1997 443 450
167. D.-C. Chu, C.-K. Chuang, J.-B. Fu, H.-S. Huang, C.-P. Tseng, and C.-F. Sun The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma The Journal of Urology 167 2002 1854 1858
168. M. Yamanaka, M. Watanabe, Y. Yamada, A. Takagi, T. Murata, H. Takahashi, H. Suzuki, H. Ito, H. Tsukino, T. Katoh, Y. Sugimura, and T. Shiraishi Altered methylation of multiple genes in carcinogenesis of the prostate International Journal of Cancer. Journal International Du Cancer 106 2003 382 387
169. S.V. Harden, H. Sanderson, S.N. Goodman, A.A.W. Partin, P.C. Walsh, J.I. Epstein, and D. Sidransky Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies Journal of the National Cancer Institute 95 2003 1634 1637
170. C. Jerónimo, R. Henrique, M.O. Hoque, E. Mambo, F.R. Ribeiro, G. Varzim, J. Oliveira, M.R. Teixeira, C. Lopes, and D. Sidransky A quantitative promoter methylation profile of prostate cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10 2004 8472 8478
171. Y. Tokumaru, S.V. Harden, D.-I. Sun, K. Yamashita, J.I. Epstein, and D. Sidransky Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10 2004 5518 5522
172. M. Zhou, Y. Tokumaru, D. Sidransky, and J.I. Epstein Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies The Journal of Urology 171 2004 2195 2198
173. S. Yegnasubramanian, J. Kowalski, M.L. Gonzalgo, M. Zahurak, S. Piantadosi, P.C. Walsh, G.S. Bova, A.M. De Marzo, W.B. Isaacs, and W.G. Nelson Hypermethylation of CpG islands in primary and metastatic human prostate cancer Cancer Research 64 2004 1975 1986
174. H. Enokida, H. Shiina, S. Urakami, M. Igawa, T. Ogishima, L.-C. Li, M. Kawahara, M. Nakagawa, C.J. Kane, P.R. Carroll, and R. Dahiya Multigene methylation analysis for detection and staging of prostate cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11 2005 6582 6588
175. A.C. Grover, M.A. Tangrea, K.G. Woodson, B.S. Wallis, J.C. Hanson, R.F. Chuaqui, J.W. Gillespie, H.S. Erickson, R.F. Bonner, T.J. Pohida, M.R. Emmert-Buck, and S.K. Libutti Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer Journal of Translational Medicine 4 2006 13
176. J. Rodriguez-Canales, J.C. Hanson, M.A. Tangrea, H.S. Erickson, P.S. Albert, B.S. Wallis, A.M. Richardson, P.A. Pinto, W.M. Linehan, J.W. Gillespie, M.J. Merino, S.K. Libutti, K.G. Woodson, M.R. Emmert-Buck, and R.F. Chuaqui Identification of a unique epigenetic sub-microenvironment in prostate cancer The Journal of Pathology 211 2007 410 419
177. B. Kwabi-Addo, S. Wang, W. Chung, J. Jelinek, S.R. Patierno, B.-D. Wang, R. Andrawis, N.H. Lee, V. Apprey, J.-P. Issa, and M. Ittmann Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16 2010 3539 3547
178. N. Vasiljević, K. Wu, A.R. Brentnall, D.C. Kim, M.A. Thorat, S.C. Kudahetti, X. Mao, L. Xue, Y. Yu, G.L. Shaw, L. Beltran, Y.-J. Lu, D.M. Berney, J. Cuzick, and A.T. Lorincz Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing Disease Markers 30 2011 151 161
179. L. Delgado-Cruzata, G.W. Hruby, K. Gonzalez, J. McKiernan, M.C. Benson, R.M. Santella, and J. Shen DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer DNA and Cell Biology 31 2012 187 192
180. P.J. Bastian, S. Yegnasubramanian, G.S. Palapattu, C.G. Rogers, X. Lin, A.M. De Marzo, and W.G. Nelson Molecular biomarker in prostate cancer: the role of CpG island hypermethylation European Urology 46 2004 698 708
181. M. Nakayama, C.J. Bennett, J.L. Hicks, J.I. Epstein, E.A. Platz, W.G. Nelson, and A.M. De Marzo Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection The American Journal of Pathology 163 2003 923 933
182. R. Henrique, C. Jeronimo, M.R. Teixeira, M.O. Hoque, A.L. Carvalho, I. Pais, F.R. Ribeiro, J. Oliveira, C. Lopes, and D. Sidransky Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis Molecular Cancer Research: MCR 4 2006 1 8
183. C. Jeronimo, H. Usadel, R. Henrique, J. Oliveira, C. Lopes, W.G. Nelson, and D. Sidransky Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma Journal of the National Cancer Institute 93 2001 1747 1752
184. C.I. Suh, T. Shanafelt, D.J. May, K.R. Shroyer, J.B. Bobak, E.D. Crawford, G.J. Miller, N. Markham, and L.M. Glode Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer Molecular and Cellular Probes 14 2000 211 217
185. C. Goessl, H. Krause, M. Müller, R. Heicappell, M. Schrader, J. Sachsinger, and K. Miller Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids Cancer Research 60 2000 5941 5945
186. P. Cairns, M. Esteller, J.G. Herman, M. Schoenberg, C. Jeronimo, M. Sanchez-Cespedes, N.H. Chow, M. Grasso, L. Wu, W.B. Westra, and D. Sidransky Molecular detection of prostate cancer in urine by GSTP1 hypermethylation Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7 2001 2727 2730
187. C. Goessl, M. Müller, R. Heicappell, H. Krause, and K. Miller DNA-based detection of prostate cancer in blood, urine, and ejaculates Annals of the New York Academy of Sciences 945 2001 51 58
188. C. Goessl, M. Müller, R. Heicappell, H. Krause, B. Straub, M. Schrader, and K. Miller DNA-based detection of prostate cancer in urine after prostatic massage Urology 58 2001 335 338
189. M.L. Gonzalgo, M. Nakayama, S.M. Lee, A.M. De Marzo, and W.G. Nelson Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis Urology 63 2004 414 418
190. M.O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W.H. Westra, and D. Sidransky Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23 2005 6569 6575
191. E. Papadopoulou, E. Davilas, V. Sotiriou, E. Georgakopoulos, S. Georgakopoulou, A. Koliopanos, F. Aggelakis, K. Dardoufas, N.J. Agnanti, I. Karydas, and G. Nasioulas Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer Annals of the New York Academy of Sciences 1075 2006 235 243
192. M. Rouprêt, V. Hupertan, D.R. Yates, J.W.F. Catto, I. Rehman, M. Meuth, S. Ricci, R. Lacave, G. Cancel-Tassin, A. de la Taille, F. Rozet, X. Cathelineau, G. Vallancien, F.C. Hamdy, and O. Cussenot Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13 2007 1720 1725
193. J. Ellinger, K. Haan, L.C. Heukamp, P. Kahl, R. Büttner, S.C. Müller, A. von Ruecker, and P.J. Bastian CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer The Prostate 68 2008 42 49
194. K. Woodson, K.J. O'Reilly, J.C. Hanson, D. Nelson, E.L. Walk, and J.A. Tangrea The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer The Journal of Urology 179 2008 508 511 discussion 511-512-508-511; discussion 511-512
195. E. Sunami, M. Shinozaki, C.S. Higano, R. Wollman, T.B. Dorff, S.J. Tucker, S.R. Martinez, R. Mizuno, F.R. Singer, and D.S.B. Hoon Multimarker circulating DNA assay for assessing blood of prostate cancer patients Clinical Chemistry 55 2009 559 567
196. M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, and J.G. Herman Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Research 59 1999 793 797
197. F.V. Jacinto, and M. Esteller MGMT hypermethylation: a prognostic foe, a predictive friend DNA Repair 6 2007 1155 1160
198. A. von Deimling, A. Korshunov, and C. Hartmann The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations Brain Pathology (Zurich, Switzerland) 21 2011 74 87
199. T. Nakagawachi, H. Soejima, T. Urano, W. Zhao, K. Higashimoto, Y. Satoh, S. Matsukura, S. Kudo, Y. Kitajima, H. Harada, K. Furukawa, H. Matsuzaki, M. Emi, Y. Nakabeppu, K. Miyazaki, M. Sekiguchi, and T. Mukai Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer Oncogene 22 2003 8835 8844
200. G. Tabatabai, R. Stupp, M.J. van den Bent, M.E. Hegi, J.C. Tonn, W. Wick, and M. Weller Molecular diagnostics of gliomas: the clinical perspective Acta Neuropathologica 120 2010 585 592
201. E. Crinière, G. Kaloshi, F. Laigle-Donadey, J. Lejeune, N. Auger, A. Benouaich-Amiel, S. Everhard, K. Mokhtari, M. Polivka, J.-Y. Delattre, K. Hoang-Xuan, J. Thillet, and M. Sanson MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities Journal of Neuro-Oncology 83 2007 173 179
202. M.E. Hegi, A.-C. Diserens, T. Gorlia, M.-F. Hamou, N. de Tribolet, M. Weller, J.M. Kros, J.A. Hainfellner, W. Mason, L. Mariani, J.E.C. Bromberg, P. Hau, R.O. Mirimanoff, J.G. Cairncross, R.C. Janzer, and R. Stupp MGMT gene silencing and benefit from temozolomide in glioblastoma The New England Journal of Medicine 352 2005 997 1003
203. A.A. Brandes, A. Tosoni, G. Cavallo, M. Reni, E. Franceschi, L. Bonaldi, R. Bertorelle, M. Gardiman, C. Ghimenton, P. Iuzzolino, A. Pession, V. Blatt, and M. Ermani Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24 2006 4746 4753
204. I. Vlassenbroeck, S. Califice, A.-C. Diserens, E. Migliavacca, J. Straub, I. Di Stefano, F. Moreau, M.-F. Hamou, I. Renard, M. Delorenzi, B. Flamion, J. DiGuiseppi, K. Bierau, and M.E. Hegi Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma The Journal of Molecular Diagnostics: JMD 10 2008 332 337
205. K. Hattermann, H.M. Mehdorn, R. Mentlein, S. Schultka, and J. Held-Feindt A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis Analytical Biochemistry 377 2008 62 71
206. T. Mikeska, C. Bock, O. El-Maarri, A. Hübner, D. Ehrentraut, J. Schramm, J. Felsberg, P. Kahl, R. Büttner, T. Pietsch, and A. Waha Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis The Journal of Molecular Diagnostics: JMD 9 2007 368 381
207. J.W.M. Jeuken, S.J.B. Cornelissen, M. Vriezen, M.M.G. Dekkers, A. Errami, A. Sijben, S.H.E. Boots-Sprenger, and P. Wesseling MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas, Laboratory Investigation A Journal of Technical Methods and Pathology 87 2007 1055 1065
208. W. Wick, C. Hartmann, C. Engel, M. Stoffels, J. Felsberg, F. Stockhammer, M.C. Sabel, S. Koeppen, R. Ketter, R. Meyermann, M. Rapp, C. Meisner, R.D. Kortmann, T. Pietsch, O.D. Wiestler, U. Ernemann, M. Bamberg, G. Reifenberger, A. von Deimling, and M. Weller NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27 2009 5874 5880
209. M.J. van den Bent, H.J. Dubbink, M. Sanson, C.R. van der Lee-Haarloo, M. Hegi, J.W.M. Jeuken, A. Ibdaih, A.A. Brandes, M.J.B. Taphoorn, M. Frenay, D. Lacombe, T. Gorlia, W.N.M. Dinjens, and J.M. Kros MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27 2009 5881 5886
210. C. Hartmann, B. Hentschel, M. Tatagiba, J. Schramm, O. Schnell, C. Seidel, R. Stein, G. Reifenberger, T. Pietsch, A. von Deimling, M. Loeffler, and M. Weller Molecular markers in low-grade gliomas: predictive or prognostic? Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17 2011 4588 4599
211. A.E. Pegg Repair of O(6)-alkylguanine by alkyltransferases Mutation Research 462 2000 83 100
212. U. Herrlinger, J. Rieger, D. Koch, S. Loeser, B. Blaschke, R.-D. Kortmann, J.P. Steinbach, T. Hundsberger, W. Wick, R. Meyermann, T.-C. Tan, C. Sommer, M. Bamberg, G. Reifenberger, and M. Weller Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03 Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24 2006 4412 4417
213. A.A. Brandes, E. Franceschi, A. Tosoni, V. Blatt, A. Pession, G. Tallini, R. Bertorelle, S. Bartolini, F. Calbucci, A. Andreoli, G. Frezza, M. Leonardi, F. Spagnolli, and M. Ermani MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26 2008 2192 2197
214. M. Weller, J. Felsberg, C. Hartmann, H. Berger, J.P. Steinbach, J. Schramm, M. Westphal, G. Schackert, M. Simon, J.C. Tonn, O. Heese, D. Krex, G. Nikkhah, T. Pietsch, O. Wiestler, G. Reifenberger, A. von Deimling, and M. Loeffler Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German glioma network Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27 2009 5743 5750
215. A. Wick, J. Felsberg, J.P. Steinbach, U. Herrlinger, M. Platten, B. Blaschke, R. Meyermann, G. Reifenberger, M. Weller, and W. Wick Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25 2007 3357 3361
216. A.A. Brandes, A. Tosoni, E. Franceschi, G. Sotti, G. Frezza, P. Amistà, L. Morandi, F. Spagnolli, and M. Ermani Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27 2009 1275 1279
217. A.M. Donson, S.O. Addo-Yobo, M.H. Handler, L. Gore, and N.K. Foreman MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma Pediatric Blood & Cancer 48 2007 403 407
218. S. Schlosser, S. Wagner, J. Mühlisch, M. Hasselblatt, J. Gerss, J.E.A. Wolff, and M.C. Frühwald MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience Pediatric Blood & Cancer 54 2010 228 237
219. M. Möllemann, M. Wolter, J. Felsberg, V.P. Collins, and G. Reifenberger Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors International Journal of Cancer. Journal International Du Cancer 113 2005 379 385
220. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J.-Y. Delattre Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27 2009 4150 4154
221. T. Watanabe, M. Nakamura, J.M. Kros, C. Burkhard, Y. Yonekawa, P. Kleihues, and H. Ohgaki Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas Acta Neuropathologica 103 2002 267 275
222. J. Felsberg, M. Wolter, H. Seul, B. Friedensdorf, M. Göppert, M.C. Sabel, and G. Reifenberger Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing Acta Neuropathologica 119 2010 501 507
223. C.S. Weirich, J.P. Erzberger, and Y. Barral The septin family of GTPases: architecture and dynamics Nature Reviews Molecular Cell Biology 9 2008 478 489
224. J. Shankar, A. Messenberg, J. Chan, T.M. Underhill, L.J. Foster, and I.R. Nabi Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells Cancer Research 70 2010 3780 3790
225. G. Liang, C.E. Salem, M.C. Yu, H.D. Nguyen, F.A. Gonzales, T.T. Nguyen, P.W. Nichols, and P.A. Jones DNA methylation differences associated with tumor tissues identified by genome scanning analysis Genomics 53 1998 260 268
226. F. Model, N. Osborn, D. Ahlquist, R. Gruetzmann, B. Molnar, F. Sipos, O. Galamb, C. Pilarsky, H.-D. Saeger, Z. Tulassay, K. Hale, S. Mooney, J. Lograsso, P. Adorjan, R. Lesche, A. Dessauer, J. Kleiber, B. Porstmann, A. Sledziewski, and C. Lofton-Day Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease Molecular Cancer Research: MCR 5 2007 153 163
227. C. Lofton-Day, F. Model, T. Devos, R. Tetzner, J. Distler, M. Schuster, X. Song, R. Lesche, V. Liebenberg, M. Ebert, B. Molnar, R. Grützmann, C. Pilarsky, and A. Sledziewski DNA methylation biomarkers for blood-based colorectal cancer screening Clinical Chemistry 54 2008 414 423
228. R. Grützmann, B. Molnar, C. Pilarsky, J.K. Habermann, P.M. Schlag, H.D. Saeger, S. Miehlke, T. Stolz, F. Model, U.J. Roblick, H.-P. Bruch, R. Koch, V. Liebenberg, T. Devos, X. Song, R.H. Day, A.Z. Sledziewski, and C. Lofton-Day Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay PloS One 3 2008 e3759
229. T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, J. Distler, K.V. Steiger, R. Grützmann, C. Pilarsky, J.K. Habermann, P.R. Fleshner, B.M. Oubre, R. Day, A.Z. Sledziewski, and C. Lofton-Day Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clinical Chemistry 55 2009 1337 1346
230. M. Tänzer, B. Balluff, J. Distler, K. Hale, A. Leodolter, C. Röcken, B. Molnar, R. Schmid, C. Lofton-Day, T. Schuster, and M.P.A. Ebert Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions PloS One 5 2010 e9061
231. J.D. Warren, W. Xiong, A.M. Bunker, C.P. Vaughn, L.V. Furtado, W.L. Roberts, J.C. Fang, W.S. Samowitz, and K.A. Heichman Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer BMC Medicine 9 2011 133
232. W. Atkin Options for screening for colorectal cancer Scandinavian Journal of Gastroenterology Suppl 2003 13 16
233. B. Richardson Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells Human Immunology 17 1986 456 470
234. C.C. Liu, T.J. Fang, T.T. Ou, C.C. Wu, R.N. Li, Y.C. Lin, C.H. Lin, W.C. Tsai, H.W. Liu, and J.H. Yen Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis Immunology Letters 135 2011 96 99
235. M. Neidhart, J. Rethage, S. Kuchen, P. Kunzler, R.M. Crowl, M.E. Billingham, R.E. Gay, and S. Gay Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression Arthritis & Rheumatism 43 2000 2634 2647
236. W. Lei, Y. Luo, K. Yan, S. Zhao, Y. Li, X. Qiu, Y. Zhou, H. Long, M. Zhao, Y. Liang, Y. Su, and Q. Lu Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis Scandinavian Journal of Rheumatology 38 2009 369 374
237. N. Takami, K. Osawa, Y. Miura, K. Komai, M. Taniguchi, M. Shiraishi, K. Sato, T. Iguchi, K. Shiozawa, A. Hashiramoto, and S. Shiozawa Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells Arthritis & Rheumatism 54 2006 779 787
238. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
239. T. Tahara, T. Shibata, M. Nakamura, H. Yamashita, D. Yoshioka, M. Okubo, N. Maruyama, T. Kamano, Y. Kamiya, H. Fujita, Y. Nakagawa, M. Nagasaka, M. Iwata, K. Takahama, M. Watanabe, H. Nakano, I. Hirata, and T. Arisawa Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC) Clinical and Experimental Medicine 9 2009 125 130
240. T. Tahara, T. Shibata, M. Nakamura, H. Yamashita, D. Yoshioka, M. Okubo, N. Maruyama, T. Kamano, Y. Kamiya, Y. Nakagawa, H. Fujita, M. Nagasaka, M. Iwata, K. Takahama, M. Watanabe, I. Hirata, and T. Arisawa Effect of MDR1 gene promoter methylation in patients with ulcerative colitis International Journal of Molecular Medicine 23 2009 521 527
241. H.S. McGee, and D.K. Agrawal TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma Immunologic Research 35 2006 219 232
242. J. Zhu, and W.E. Paul CD4 T cells: fates, functions, and faults Blood 112 2008 1557 1569
243. B.M. Javierre, H. Hernando, and E. Ballestar Environmental triggers and epigenetic deregulation in autoimmune disease Discovery Medicine 12 2011 535 545
244. H.M. Abdolmaleky, K.H. Cheng, A. Russo, C.L. Smith, S.V. Faraone, M. Wilcox, R. Shafa, S.J. Glatt, G. Nguyen, J.F. Ponte, S. Thiagalingam, and M.T. Tsuang Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 134B 2005 60 66
245. D.R. Grayson, X. Jia, Y. Chen, R.P. Sharma, C.P. Mitchell, A. Guidotti, and E. Costa Reelin promoter hypermethylation in schizophrenia Proceedings of the National Academy of Sciences of the United States of America 102 2005 9341 9346
246. K. Iwamoto, M. Bundo, K. Yamada, H. Takao, Y. Iwayama-Shigeno, T. Yoshikawa, and T. Kato DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia Journal of Neuroscience 25 2005 5376 5381
247. H.M. Abdolmaleky, S. Yaqubi, P. Papageorgis, A.W. Lambert, S. Ozturk, V. Sivaraman, and S. Thiagalingam Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder Schizophrenia Research 129 2011 183 190
248. A. Tolosa, J. Sanjuan, A.M. Dagnall, M.D. Molto, N. Herrero, and R. de Frutos FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies BMC Medical Genetics 11 2010 114
249. H.M. Abdolmaleky, K.H. Cheng, S.V. Faraone, M. Wilcox, S.J. Glatt, F. Gao, C.L. Smith, R. Shafa, B. Aeali, J. Carnevale, H. Pan, P. Papageorgis, J.F. Ponte, V. Sivaraman, M.T. Tsuang, and S. Thiagalingam Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Human Molecular Genetics 15 2006 3132 3145
250. H.M. Abdolmaleky, and S. Thiagalingam Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis? Epigenomics 3 2011 679 683
251. G. Toperoff, D. Aran, J.D. Kark, M. Rosenberg, T. Dubnikov, B. Nissan, J. Wainstein, Y. Friedlander, E. Levy-Lahad, B. Glaser, and A. Hellman Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood Human Molecular Genetics 21 2012 371 383
252. B.C. Christensen, and C.J. Marsit Epigenomics in environmental health Frontiers in Genetics 2 2011 84
253. C. Bock, J. Walter, M. Paulsen, and T. Lengauer Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping Nucleic Acids Research 36 2008 e55
254. V.K. Rakyan, T.A. Down, D.J. Balding, and S. Beck Epigenome-wide association studies for common human diseases Nature Reviews Genetics 12 2011 529 541
255. D.H. Lim, and E.R. Maher Genomic imprinting syndromes and cancer Advances in Genetics 70 2010 145 175
256. J. Demars, and C. Gicquel Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes Clinical Genetics 2011
257. S.C. Ramsden, J. Clayton-Smith, R. Birch, and K. Buiting Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes BMC Medical Genetics 11 2010 70
258. D.K. Bourque, M.S. Penaherrera, R.K. Yuen, M.I. Van Allen, D.E. McFadden, and W.P. Robinson The utility of quantitative methylation assays at imprinted genes for the diagnosis of fetal and placental disorders Clinical Genetics 79 2011 169 175
259. D.C. Bittel, N. Kibiryeva, and M.G. Butler Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities Genetic Testing 11 2007 467 475
260. M. Alders, J. Bliek, K. vd Lip, R. vd Bogaard, and M. Mannens Determination of KCNQ1OT1 and H19 methylation levels in BWS and SRS patients using methylation-sensitive high-resolution melting analysis European Journal of Human Genetics 17 2009 467 473
261. C.F. Wright, and H. Burton The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis Human Reproduction Update 15 2009 139 151
262. Y. Li, W. Holzgreve, V. Kiefer, and S. Hahn Maldi-tof mass spectrometry compared with real-time PCR for detection of fetal cell-free DNA in maternal plasma Clinical Chemistry 52 2006 2311 2312
263. C. Ding, R.W. Chiu, T.K. Lau, T.N. Leung, L.C. Chan, A.Y. Chan, P. Charoenkwan, I.S. Ng, H.Y. Law, E.S. Ma, X. Xu, C. Wanapirak, T. Sanguansermsri, C. Liao, M.A. Ai, D.H. Chui, C.R. Cantor, and Y.M. Lo MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis Proceedings of the National Academy of Sciences of the United States of America 101 2004 10762 10767
264. T. Chu, B. Burke, K. Bunce, U. Surti, W. Allen Hogge, and D.G. Peters A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease Prenatal Diagnosis 29 2009 1020 1030
265. E.A. Papageorgiou, H. Fiegler, V. Rakyan, S. Beck, M. Hulten, K. Lamnissou, N.P. Carter, and P.C. Patsalis Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies American Journal of Pathology 174 2009 1609 1618
266. A.O. Nygren, J. Dean, T.J. Jensen, S. Kruse, W. Kwong, D. van den Boom, and M. Ehrich Quantification of fetal DNA by use of methylation-based DNA discrimination Clinical Chemistry 56 2010 1627 1635
267. S.S. Chim, Y.K. Tong, R.W. Chiu, T.K. Lau, T.N. Leung, L.Y. Chan, C.B. Oudejans, C. Ding, and Y.M. Lo Detection of the placental epigenetic signature of the maspin gene in maternal plasma Proceedings of the National Academy of Sciences of the United States of America 102 2005 14753 14758
268. D.J. Huang, M.R. Nelson, B. Zimmermann, L. Dudarewicz, F. Wenzel, R. Spiegel, B. Nagy, W. Holzgreve, and S. Hahn Reliable detection of trisomy 21 using MALDI-TOF mass spectrometry Genetics in Medicine 8 2006 728 734
269. N.B. Tsui, R.W. Chiu, C. Ding, A. El-Sheikhah, T.N. Leung, T.K. Lau, K.H. Nicolaides, and Y.M. Lo Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms Clinical Chemistry 51 2005 2358 2362
270. E.A. Papageorgiou, and P.C. Patsalis Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications Genome Medicicne 4 2012 46
271. T.J. Jensen, Z. Dzakula, C. Deciu, D. van den Boom, and M. Ehrich Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma Clinical Chemistry 58 2012 1148 1151
272. R.W. Chiu, K.C. Chan, Y. Gao, V.Y. Lau, W. Zheng, T.Y. Leung, C.H. Foo, B. Xie, N.B. Tsui, F.M. Lun, B.C. Zee, T.K. Lau, C.R. Cantor, and Y.M. Lo Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma Proceedings of the National Academy of Sciences of the United States of America 105 2008 20458 20463
273. Y.K. Tong, C. Ding, R.W. Chiu, A. Gerovassili, S.S. Chim, T.Y. Leung, T.N. Leung, T.K. Lau, K.H. Nicolaides, and Y.M. Lo Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations Clinical Chemistry 52 2006 2194 2202
274. Y.K. Tong, R.W. Chiu, R. Akolekar, T.Y. Leung, T.K. Lau, K.H. Nicolaides, and Y.M. Lo Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker PLoS ONE 5 2010 e15244
275. J.H. Lim, S.Y. Kim, S.Y. Park, S.Y. Lee, M.J. Kim, Y.J. Han, S.W. Lee, J.H. Chung, M.Y. Kim, J.H. Yang, and H.M. Ryu Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma PLoS ONE 6 2011 e27709
276. S.S. Chim, S. Jin, T.Y. Lee, F.M. Lun, W.S. Lee, L.Y. Chan, Y. Jin, N. Yang, Y.K. Tong, T.Y. Leung, T.K. Lau, C. Ding, R.W. Chiu, and Y.M. Lo Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21 Clinical Chemistry 54 2008 500 511
277. E.A. Papageorgiou, A. Karagrigoriou, E. Tsaliki, V. Velissariou, N.P. Carter, and P.C. Patsalis Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21 Nature Medicine 17 2011 510 513
278. F. Mujezinovic, and Z. Alfirevic Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review Obstetrics & Gynecology 110 2007 687 694
279. I. Hatada, Y. Hayashizaki, S. Hirotsune, H. Komatsubara, and T. Mukai A genomic scanning method for higher organisms using restriction sites as landmarks Proceedings of the National Academy of Sciences of the United States of America 88 1991 9523 9527
280. D.J. Smiraglia, and C. Plass The study of aberrant methylation in cancer via restriction landmark genomic scanning Oncogene 21 2002 5414 5426
281. D.J. Smiraglia, R. Kazhiyur-Mannar, C.C. Oakes, Y.Z. Wu, P. Liang, T. Ansari, J. Su, L.J. Rush, L.T. Smith, L. Yu, C. Liu, Z. Dai, S.S. Chen, S.H. Wang, J. Costello, I. Ioshikhes, D.W. Dawson, J.S. Hong, M.A. Teitell, A. Szafranek, M. Camoriano, F. Song, R. Elliott, W. Held, J.M. Trasler, C. Plass, and R. Wenger Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations BMC Genomics 8 2007 446
282. P.S. Yan, M.R. Perry, D.E. Laux, A.L. Asare, C.W. Caldwell, and T.H. Huang CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 6 2000 1432 1438
283. G. Liang, M.L. Gonzalgo, C. Salem, and P.A. Jones Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction Methods 27 2002 150 155
284. J. Frigola, M. Ribas, R.A. Risques, and M.A. Peinado Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS) Nucleic Acids Research 30 2002 e28
285. M. Bibikova, Z. Lin, L. Zhou, E. Chudin, E.W. Garcia, B. Wu, D. Doucet, N.J. Thomas, Y. Wang, E. Vollmer, T. Goldmann, C. Seifart, W. Jiang, D.L. Barker, M.S. Chee, J. Floros, and J.B. Fan High-throughput DNA methylation profiling using universal bead arrays Genome Research 16 2006 383 393
286. A.S. Ishkanian, C.A. Malloff, S.K. Watson, R.J. DeLeeuw, B. Chi, B.P. Coe, A. Snijders, D.G. Albertson, D. Pinkel, M.A. Marra, V. Ling, C. MacAulay, and W.L. Lam A tiling resolution DNA microarray with complete coverage of the human genome Nature Genetics 36 2004 299 303
287. T. Rauch, H. Li, X. Wu, and G.P. Pfeifer MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells Cancer Research 66 2006 7939 7947
288. T.A. Rauch, and G.P. Pfeifer DNA methylation profiling using the methylated-CpG island recovery assay (MIRA) Methods 52 2010 213 217
289. B. Khulan, R.F. Thompson, K. Ye, M.J. Fazzari, M. Suzuki, E. Stasiek, M.E. Figueroa, J.L. Glass, Q. Chen, C. Montagna, E. Hatchwell, R.R. Selzer, T.A. Richmond, R.D. Green, A. Melnick, and J.M. Greally Comparative isoschizomer profiling of cytosine methylation: the HELP assay Genome Research 16 2006 1046 1055
290. M. Oda, J.L. Glass, R.F. Thompson, Y. Mo, E.N. Olivier, M.E. Figueroa, R.R. Selzer, T.A. Richmond, X. Zhang, L. Dannenberg, R.D. Green, A. Melnick, E. Hatchwell, E.E. Bouhassira, A. Verma, M. Suzuki, and J.M. Greally High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers Nucleic Acids Research 37 2009 3829 3839
291. R. Lister, M. Pelizzola, R.H. Dowen, R.D. Hawkins, G. Hon, J. Tonti-Filippini, J.R. Nery, L. Lee, Z. Ye, Q.M. Ngo, L. Edsall, J. Antosiewicz-Bourget, R. Stewart, V. Ruotti, A.H. Millar, J.A. Thomson, B. Ren, and J.R. Ecker Human DNA methylomes at base resolution show widespread epigenomic differences Nature 462 2009 315 322
292. M.J. Booth, M.R. Branco, G. Ficz, D. Oxley, F. Krueger, W. Reik, and S. Balasubramanian Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution Science 336 2012 934 937
293. D. Serre, B.H. Lee, and A.H. Ting MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome Nucleic Acids Research 38 2010 391 399
294. A. Meissner, A. Gnirke, G.W. Bell, B. Ramsahoye, E.S. Lander, and R. Jaenisch Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis Nucleic Acids Research 33 2005 5868 5877
295. E.J. Lee, L. Pei, G. Srivastava, T. Joshi, G. Kushwaha, J.H. Choi, K.D. Robertson, X. Wang, J.K. Colbourne, L. Zhang, G.P. Schroth, D. Xu, K. Zhang, and H. Shi Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing Nucleic Acids Research 39 2011 e127
296. S. Nautiyal, V.E. Carlton, Y. Lu, J.S. Ireland, D. Flaucher, M. Moorhead, J.W. Gray, P. Spellman, M. Mindrinos, P. Berg, and M. Faham High-throughput method for analyzing methylation of CpGs in targeted genomic regions Proceedings of the National Academy of Sciences of the United States of America 107 2010 12587 12592
297. K.E. Varley, and R.D. Mitra Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples Genome Research 20 2010 1279 1287
298. E. Hodges, A.D. Smith, J. Kendall, Z. Xuan, K. Ravi, M. Rooks, M.Q. Zhang, K. Ye, A. Bhattacharjee, L. Brizuela, W.R. McCombie, M. Wigler, G.J. Hannon, and J.B. Hicks High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing Genome Research 19 2009 1593 1605
299. D. Diep, N. Plongthongkum, A. Gore, H.L. Fung, R. Shoemaker, and K. Zhang Library-free methylation sequencing with bisulfite padlock probes Nature Methods 9 2012 270 272
300. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proceedings of the National Academy of Sciences of the United States of America 93 1996 9821 9826
301. J. Tost, and I.G. Gut DNA methylation analysis by pyrosequencing Nature Protocols 2 2007 2265 2275
302. Y. Zhang, C. Rohde, S. Tierling, T.P. Jurkowski, C. Bock, D. Santacruz, S. Ragozin, R. Reinhardt, M. Groth, J. Walter, and A. Jeltsch DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution PLoS Genetics 5 2009 e1000438
303. M.L. Gonzalgo, and P.A. Jones Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE) Nucleic Acids Research 25 1997 2529 2531
304. Z.A. Kaminsky, A. Assadzadeh, J. Flanagan, and A. Petronis Single nucleotide extension technology for quantitative site-specific evaluation of metC/C in GC-rich regions Nucleic Acids Research 33 2005 e95
305. Z. Xiong, and P.W. Laird COBRA: a sensitive and quantitative DNA methylation assay Nucleic Acids Research 25 1997 2532 2534
306. A.O. Nygren, N. Ameziane, H.M. Duarte, R.N. Vijzelaar, Q. Waisfisz, C.J. Hess, J.P. Schouten, and A. Errami Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences Nucleic Acids Research 33 2005 e128
307. M. Ehrich, M.R. Nelson, P. Stanssens, M. Zabeau, T. Liloglou, G. Xinarianos, C.R. Cantor, J.K. Field, and D. van den Boom Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry Proceedings of the National Academy of Sciences of the United States of America 102 2005 15785 15790
308. M.W. Coolen, A.L. Statham, M. Gardiner-Garden, and S.J. Clark Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements Nucleic Acids Research 35 2007 e119
309. R. Krassenstein, E. Sauter, E. Dulaimi, C. Battagli, H. Ehya, A. Klein-Szanto, and P. Cairns Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation Clinical Cancer Research 10 2004 28 32
310. C. Jeronimo, P. Monteiro, R. Henrique, M. Dinis-Ribeiro, I. Costa, V.L. Costa, L. Filipe, A.L. Carvalho, M.O. Hoque, I. Pais, C. Leal, M.R. Teixeira, and D. Sidransky Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions Breast Cancer Research and Treatment 109 2008 27 34
311. Y.C. Antill, G. Mitchell, S.A. Johnson, L. Devereux, A. Milner, J. Di Iulio, G.J. Lindeman, J. Kirk, K.A. Phillips, and I.G. Campbell Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers Cancer Epidemiology, Biomarkers & Prevention 19 2010 265 274
312. A. Lee, Y. Kim, K. Han, C.S. Kang, H.M. Jeon, and S.I. Shim Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast Archives of Pathology & Laboratory Medicine 128 2004 1251 1256
313. J.C. Soria, M. Rodriguez, D.D. Liu, J.J. Lee, W.K. Hong, and L. Mao Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers Cancer Research 62 2002 351 355
314. F. de Fraipont, D. Moro-Sibilot, S. Michelland, E. Brambilla, C. Brambilla, and M.C. Favrot Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer? Lung Cancer 50 2005 199 209
315. R. Cirincione, C. Lintas, D. Conte, L. Mariani, L. Roz, A.M. Vignola, U. Pastorino, and G. Sozzi Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study International Journal of Cancer 118 2006 1248 1253
316. S.A. Belinsky, W.A. Palmisano, F.D. Gilliland, L.A. Crooks, K.K. Divine, S.A. Winters, M.J. Grimes, H.J. Harms, C.S. Tellez, T.M. Smith, P.P. Moots, J.F. Lechner, C.A. Stidley, and R.E. Crowell Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers Cancer Research 62 2002 2370 2377
317. A.A. Melnikov, D. Scholtens, M.S. Talamonti, D.J. Bentrem, and V.V. Levenson Methylation profile of circulating plasma DNA in patients with pancreatic cancer Journal of Surgical Oncology 99 2009 119 122
318. R. Kandimalla, A.A. van Tilborg, L.C. Kompier, D.J. Stumpel, R.W. Stam, C.H. Bangma, and E.C. Zwarthoff Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers European Urology 61 2012 1245 1256
319. T. Reinert, C. Modin, F.M. Castano, P. Lamy, T.K. Wojdacz, L.L. Hansen, C. Wiuf, M. Borre, L. Dyrskjot, and T.F. Orntoft Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers Clinical Cancer Research 17 2011 5582 5592
320. S. Eissa, M. Swellam, I.M. El-Khouly, S.K. Kassim, H. Shehata, A. Mansour, M. Esmat, A.I. Nossier, M.A. Hamdy, N.M. Awad, and O. El-Ahmady Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer Cancer Epidemiology, Biomarkers & Prevention 20 2011 1657 1664
321. H. Kamiyama, H. Noda, O. Takata, K. Suzuki, Y. Kawamura, and F. Konishi Promoter hypermethylation of tumor-related genes in peritoneal lavage and the prognosis of patients with colorectal cancer Journal of Surgical Oncology 100 2009 69 74
322. L.J. Gay, M.J. Arends, P.N. Mitrou, R. Bowman, A.E. Ibrahim, L. Happerfield, R. Luben, A. McTaggart, R.Y. Ball, and S.A. Rodwell MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk Nutrition and Cancer 63 2011 1000 1010
323. L.J. Bosch, F.A. Oort, M. Neerincx, C.A. Khalid-de Bakker, J.S. Sive Droste, V. Melotte, D.M. Jonkers, A.A. Masclee, S. Mongera, M. Grooteclaes, J. Louwagie, W. van Criekinge, V.M. Coupe, C.J. Mulder, M. van Engeland, B. Carvalho, and G.A. Meijer DNA methylation of Phosphatase and actin Regulator 3 detects colorectal cancer in stool and Complements FIT Cancer Prevention Research (Phila) 5 2012 464 472